Skip to main content
. 2024 Jan 25;11:1322773. doi: 10.3389/fchem.2023.1322773

FIGURE 3.

FIGURE 3

Pb-214/Bi-214-TCMC-Trastuzumab treatment effectively inhibits colony formation in HER2+ SKOV3 ovarian cancer cells (A,B). (A) Representative images of three groups (n = 3) and (B) summary analyses of living cells showing the Pb-214/Bi-214 response in killing SKOV-3 cells in a clonogenic assay. ****, p < 0.0001 compared to untreated control.